Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cellective Dx

2005 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of diagnostic, monitoring and molecular analytical tools for cancer. The company's diagnostic tools are based on the analysis of CTCs from patient's blood. Its technologies combine microfluids, flow dynamics, cell biology, molecular biology, biochemistry and surface chemistry to capture and analyze rare CTCs in blood.

Formerly Known As
CellPoint Diagnostics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Acquirer
On-Q-ity
Primary Office
  • 265 North Whisman Road
  • Mountain View, CA 94043
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cellective Dx’s full profile, request a free trial.

Cellective Dx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 31-May-2009 000.00 Completed Startup
5. Early Stage VC (Series B) 13-May-2009 00.000 000.00 000.00 Completed Generating Revenue
4. Convertible Debt 19-Aug-2008 000 000.00 Completed Startup
3. Early Stage VC (Series A1) 13-Sep-2007 000.00 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 16-Sep-2006 $8.5M $8.5M 000.00 Completed Startup
1. Grant 01-Jan-2006 $142K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cellective Dx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 9,806,039 $0.001000 $0.07 $0.92 $0.92 1x $0.92 21.02%
To view this company’s complete Cap Table, request access »

Cellective Dx Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Mohr Davidow Ventures Venture Capital Minority 000 0000 000000 0
Northgate Capital Fund of Funds Minority 000 0000 000000 0
Northport Investments PE/Buyout Minority 000 0000 000000 0
Paperboy Ventures Merchant Banking Firm Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0